” Whilst the Ricaurte Tale was unfolding, MAPS finally been given FDA signal-off on the protocol for human trials of MDMA being a procedure for PTSD, but only right after it purchased a $1 million insurance policy policy to indemnify the review board."It's important to bear in mind they are not illicit drugs every time they're used in analysis,"